Literature DB >> 3316463

Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages.

M Hoffman1, J B Weinberg.   

Abstract

It has recently been shown that tumor necrosis factor (TNF) induces increased Ia antigen expression on a malignant murine macrophage cell line, and that TNF is synergistic with gamma interferon (IFN) in inducing Ia expression. This finding raises the possibility that TNF serves as a non-interferon macrophage activating factor in vivo. Since it is known that TNF has different effects on malignant and benign cells, we chose to evaluate the effects of recombinant TNF on primary cultures of murine peritoneal macrophages (MP). Neither human nor murine TNF increased the proportion of MP which expressed Ia antigen, and TNF actually partially prevented the IFN-induced increase in Ia. However, culture with TNF activated MP for increased hydrogen peroxide production in response to phorbol myristate acetate (PMA) and antagonized the IFN-induced decrease in the proportion of the MP bearing receptors for the Fc region of IgG2b. TNF and IFN were additive in increasing peroxide production. Both human and murine TNF had the same effects on MP, and MP from C3H/HeN (endotoxin sensitive) and C3H/HeJ (endotoxin resistant) mice responded comparably to TNF and IFN. Our results support the hypothesis that TNF has some macrophage-activating activity, but its effects are selective and not identical with those of IFN.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316463     DOI: 10.1002/jlb.42.6.704

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

Review 1.  Tumor necrosis factor regulation of major histocompatibility complex gene expression.

Authors:  D R Johnson; J S Pober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 5.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.

Authors:  Molly A Matty; Francisco J Roca; Mark R Cronan; David M Tobin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

7.  Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.

Authors:  C M Thumwood; N H Hunt; W B Cowden; I A Clark
Journal:  Br J Exp Pathol       Date:  1989-06

8.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.

Authors:  B M Schreiber; M D Layne; E J Modest
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

10.  Pulmonary inflammation and fibrosis in a murine model of asbestosis and silicosis. Possible role of tumor necrosis factor.

Authors:  E Bissonnette; M Rola-Pleszczynski
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.